ArticleCancer science2016

Gemcitabine enhances rituximab-mediated complement-dependent cytotoxicity to B cell lymphoma by CD20 upregulation.

Kazumi Hayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.